Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Surgical nodal sampling established by Commission on Cancer Standard 5.8 is essential for accurate lung cancer staging.

JTCVS open·2026
Same author

EPR26-162: Distinct Clinical Profiles of Younger and Older Patients at Risk for Non-Small Cell Lung Cancer.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same author

An American College of Surgeons National Quality Improvement Collaborative to Enhance Lung Cancer Surgical Quality.

JAMA surgery·2026
Same author

EPR26-162: Distinct Clinical Profiles of Younger and Older Patients at Risk for Non-Small Cell Lung Cancer.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same author

3-dimensional reconstruction and mixed reality in thoracic surgery: a narrative review and user guide.

Journal of thoracic disease·2026
Same author

Making a Financial Case for the Geriatric Surgery Verification Program.

Annals of surgery open : perspectives of surgical history, education, and clinical approaches·2024
Same journal

Serious mental illness and cancer: A call to action for equitable care.

CA: a cancer journal for clinicians·2026
Same journal

Extranodal natural killer/T-cell lymphoma: From fatal to curable.

CA: a cancer journal for clinicians·2026
Same journal

Data support longer recurrence-free survival with nivolumab than with ipilimumab for stage III or IV melanoma.

CA: a cancer journal for clinicians·2026
Same journal

Study finds ovarian cancer survivors who are BRCA carriers have a relatively low risk of breast cancer.

CA: a cancer journal for clinicians·2026
Same journal

Radiation therapy, cytogenetic prognostication, novel systemic chemotherapy, and patient perspective in an adult with choroidal melanoma.

CA: a cancer journal for clinicians·2026
Same journal

Systemic amyloid light-chain amyloidosis beyond ANDROMEDA: Diagnostic challenges and therapeutic updates.

CA: a cancer journal for clinicians·2026
See all related articles

Related Experiment Video

Updated: May 31, 2026

Multidimensional Coculture System to Model Lung Squamous Carcinoma Progression
07:53

Multidimensional Coculture System to Model Lung Squamous Carcinoma Progression

Published on: March 17, 2020

ProvenCare lung cancer: a multi-institutional improvement collaborative.

Mark R Katlic1, Matthew A Facktor, Scott A Berry

  • 1Department of Thoracic Surgery, Geisinger Wyoming Valley Medical Center, Wilkes-Barre, PA, USA. mkatlic@lifebridgehealth.org

CA: a Cancer Journal for Clinicians
|July 13, 2011
PubMed
Summary
This summary is machine-generated.

Geisinger

More Related Videos

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients
07:43

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients

Published on: September 25, 2018

Related Experiment Videos

Last Updated: May 31, 2026

Multidimensional Coculture System to Model Lung Squamous Carcinoma Progression
07:53

Multidimensional Coculture System to Model Lung Squamous Carcinoma Progression

Published on: March 17, 2020

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients
07:43

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients

Published on: September 25, 2018

Area of Science:

  • Reliability science in healthcare
  • Clinical process re-engineering
  • Multicenter quality improvement initiatives

Background:

  • Geisinger's ProvenCare™ Program successfully re-engineered clinical processes for specific surgeries using reliability science.
  • The generalizability of ProvenCare to other institutions and conditions remained unestablished.
  • Lung cancer care presents complex challenges amenable to process improvement.

Purpose of the Study:

  • To adapt and evaluate the ProvenCare™ model for the care of patients with resectable lung cancer.
  • To assess the feasibility of implementing reliability science principles in a multi-institutional setting for lung cancer treatment.
  • To reduce unwarranted variation in lung cancer care through evidence-based process standardization.

Main Methods:

  • Adaptation of the ProvenCare™ framework for resectable lung cancer care.
  • Implementation across multiple institutions under the American College of Surgeons Commission on Cancer.
  • Utilizing a robust electronic health record to facilitate process management and data collection.

Main Results:

  • The ProvenCare™ model was successfully adapted for lung cancer care.
  • A multi-institutional collaborative was established to implement the adapted program.
  • The study demonstrated the potential for generalizing reliability science principles to complex oncologic care pathways.

Conclusions:

  • The ProvenCare™ program's principles can be adapted to improve lung cancer care across multiple institutions.
  • Reliability science offers a viable framework for re-engineering complex oncologic processes.
  • This multi-institutional approach shows promise for reducing variation and enhancing evidence-based care in lung cancer treatment.